Adrenomedullin and diabetes mellitus

Diabetes/Metabolism Research and Reviews

Volumn 17, Issue 5, 2001, Pages 321-329

  Ruzicska, Eva ^a   Toth, Miklos ^a   Tulassay, Zsolt ^a   Somogyi, Aniko ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Adrenomedullin; Atherosclerosis; Diabetes mellitus; Endothelial dysfunction; Vasoactive peptides

Indexed keywords

ADRENOMEDULLIN; NITRIC OXIDE; PEPTIDE HORMONE; VASOACTIVE AGENT; VASODILATOR AGENT;

AMINO ACID SEQUENCE; AUTOCRINE EFFECT; BLOOD PRESSURE; BLOOD VESSEL WALL; CHRONIC KIDNEY FAILURE; COMPLICATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE SEVERITY; ELECTROLYTE BALANCE; ENDOCRINE SYSTEM; FLUID BALANCE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; PARACRINE SIGNALING; PATHOGENESIS; PATHOLOGY; PHEOCHROMOCYTOMA; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ISOLATION; REVIEW; VASOCONSTRICTION; VASODILATATION;

ADRENOMEDULLIN; ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; PEPTIDES; PHEOCHROMOCYTOMA; RECEPTORS, PEPTIDE; SECOND MESSENGER SYSTEMS; VASODILATOR AGENTS;

EID: 0034761632     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.223     Document Type: Review

References (62)

1. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: An update
2. The pathogenesis of vascular complications of diabetes mellitus: One voice or many?
3. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
4. Insulin as a vascular hormone: Implications for the pathophysiology of cardiovascular disease
5. Insulin resistance and thrombosis: A cardiologist's view
6. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma
7. Genomic structure of human adrenomedullin gene
8. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin
9. Adrenomedullin
10. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine
11. Simple immunoradiometric assay for measuring the entire molecule of adrenomedullin in human plasma
12. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma
13. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma ganglioneuroblastoma and neuroblastoma
14. Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects
15. Adrenomedullin is inactivated in the lungs of neonatal piglets
16. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: A pharmacokinetic study
17. Orthostatic stimuli rapidly change plasma adrenomedullin in humans
18. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure
19. Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension
20. Potent and long-lasting vasodilator effects of adrenomedullin in humans: Comparisons between normal subjects and patients with chronic heart failure
21. Effect of a hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension
22. Alterations of intrarenal adrenomedullin and its receptor system in heart failure rats
23. PAMP is a novel inhibitor of the tachykinin release in the airway of guinea pigs
24. Expression of adrenomedullin in normal human lung and in pulmonary tumors
25. Samson. Adrenomedullin
26. Endothelial cells actively synthesise and secrete adrenomedullin
27. Production and secretion of adrenomedullin from vascular smooth muscle cells: Augmented production by tumor necrosis factor-α
28. Interleukin I, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells
29. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells
30. Specific receptors for adrenomedullin in cultures of rat vascular smooth muscle cells
31. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat
32. Cloning and expression of cDNA encoding a rat adrenomedullin receptor
33. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
34. Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: Cloning and upregulation in obstructive nephropathy
35. Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin rat
36. Adrenomedullin: Potential in physiology and pathophysiology
37. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases
38. Adrenomedullin: Biological actions, breakdown and radioimmunoassay
39. Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat
40. Effects of low-dose adrenomedullin on cardiac function and systemic haemodynamics in man
41. Interaction of adrenomedullin and platelet derived growth factor on the production of endothelin
42. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells
43. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells
44. Evidence for cAMP independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide
45. Increased cardiac gene expression of adrenomedullin in All induced cardiac hypertrophy in normal and adrenalectomized rats
46. An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth
47. Adrenomedullin: A possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes
48. Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats
49. Mechanism of adrenomedullin induced vasodilatation in the rat kidney
50. Intracerebroventricular injection of adrenomedullin inhibits vasopressin release in conscious rat
51. Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature
52. Plasma adrenomedullin in diabetes
53. Hyperglycemia increases vascular adrenomedullin expression
54. Plasma adrenomedullin levels in patients with diabetes
55. Adrenomedullin and proadrenomedullin N-terminal 20 peptide in impaired renal function
56. Plasma adrenomedullin levels in type 1 diabetes: Relationship with clinical parameters
57. Plasma adrenomedullin levels in patients with non-insulin-dependent diabetes mellitus: Close relationship with diabetic complications
58. Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes
59. Is adrenomedullin a causal agent in some cases of type 2 diabetes?
60. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin
61. Adrenomedullin receptor characterization using the selective antagonist adrenomedullin (22-52)
62. Adrenomedullin (16-31) has pressure activity in the rat but not in the cat